Brazzell Romulus K
Insider CIK 1298079 · KALA SEE REMARKS, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KALA KALA BIO, Inc. | S Sale | 2025-10-22 | 2025-10-24 | 46,748 | $0.83 | $38.8K | 35,952 | SEC↗ |
| KALA KALA BIO, Inc. | S Sale | 2025-06-24 | 2025-06-26 | 5,251 | $4.01 | $21.1K | 82,698 | SEC↗ |
| KALA KALA BIO, Inc. | S Sale | 2025-06-03 | 2025-06-04 | 3,687 | $3.74 | $13.8K | 87,949 | SEC↗ |
| KALA KALA BIO, Inc. | A Award deriv | 2025-01-06 | 2025-01-07 | 45,200 | — | $0 | 45,200 | SEC↗ |
| KALA KALA BIO, Inc. | S Sale | 2025-01-06 | 2025-01-07 | 2,446 | $7.63 | $18.7K | 92,418 | SEC↗ |
| KALA KALA BIO, Inc. | A Award | 2025-01-06 | 2025-01-07 | 10,100 | — | $0 | 94,864 | SEC↗ |
| KALA KALA BIO, Inc. | S Sale | 2024-06-26 | 2024-06-27 | 5,489 | $4.75 | $26.1K | 83,982 | SEC↗ |
| KALA KALA BIO, Inc. | S Sale | 2024-05-31 | 2024-06-03 | 2,002 | $6.09 | $12.2K | 89,471 | SEC↗ |
| KALA KALA BIO, Inc. | A Award deriv | 2024-01-04 | 2024-01-05 | 29,300 | — | $0 | 29,300 | SEC↗ |
| KALA KALA BIO, Inc. | S Sale | 2024-01-04 | 2024-01-05 | 1,617 | $6.74 | $10.9K | 91,473 | SEC↗ |
| KALA KALA BIO, Inc. | A Award | 2024-01-04 | 2024-01-05 | 6,500 | — | $0 | 93,090 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award deriv | 2023-06-22 | 2023-06-23 | 65,808 | — | $0 | 65,808 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award | 2023-06-22 | 2023-06-23 | 49,356 | — | $0 | 85,808 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | D To issuer deriv | 2023-05-31 | 2023-06-02 | 2,399 | — | $0 | 0 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | D To issuer deriv | 2023-05-31 | 2023-06-02 | 2,999 | — | $0 | 0 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | D To issuer deriv | 2023-05-31 | 2023-06-02 | 1,399 | — | $0 | 0 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | D To issuer deriv | 2023-05-31 | 2023-06-02 | 942 | — | $0 | 0 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | D To issuer deriv | 2023-05-31 | 2023-06-02 | 2,047 | — | $0 | 0 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | D To issuer deriv | 2023-05-31 | 2023-06-02 | 308 | — | $0 | 0 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | D To issuer deriv | 2023-05-31 | 2023-06-02 | 864 | — | $0 | 0 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | D To issuer deriv | 2023-05-31 | 2023-06-02 | 4,759 | — | $0 | 0 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | D To issuer deriv | 2023-05-31 | 2023-06-02 | 2,199 | — | $0 | 0 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award | 2023-05-31 | 2023-06-02 | 17,916 | — | $0 | 36,452 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award deriv | 2023-03-14 | 2023-03-15 | 576 | — | $0 | 576 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award | 2023-01-04 | 2023-01-06 | 12,800 | — | $0 | 18,609 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | S Sale | 2023-01-04 | 2023-01-06 | 73 | $28.53 | $2.1K | 18,536 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | S Sale | 2022-10-26 | 2022-10-28 | 261 | $6.51 | $1.7K | 5,809 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | S Sale | 2022-06-27 | 2022-06-29 | 3,144 | $0.37 | $1.2K | 285,201 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | S Sale | 2022-01-04 | 2022-01-05 | 3,504 | $1.30 | $4.6K | 288,345 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award deriv | 2022-01-03 | 2022-01-05 | 238,000 | — | $0 | 238,000 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | S Sale | 2021-10-26 | 2021-10-28 | 12,757 | $1.80 | $23.0K | 291,849 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | S Sale | 2021-06-28 | 2021-06-29 | 3,034 | $5.77 | $17.5K | 300,962 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award deriv | 2021-01-04 | 2021-01-05 | 110,000 | — | $0 | 110,000 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award | 2021-01-04 | 2021-01-05 | 27,500 | — | $0 | 303,996 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award | 2020-10-26 | 2020-10-28 | 81,000 | — | $0 | 276,496 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award | 2020-06-25 | 2020-06-29 | 19,000 | — | $0 | 195,496 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | M Exercise deriv | 2020-04-09 | 2020-04-13 | 18,247 | — | $0 | 0 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | M Exercise deriv | 2020-04-09 | 2020-04-13 | 47,644 | — | $0 | 13,508 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | M Exercise deriv | 2020-04-09 | 2020-04-13 | 1,880 | — | $0 | 0 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | M Exercise | 2020-04-09 | 2020-04-13 | 47,644 | $3.34 | $159.1K | 176,496 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | M Exercise | 2020-04-09 | 2020-04-13 | 18,247 | $2.30 | $42.0K | 128,852 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | M Exercise | 2020-04-09 | 2020-04-13 | 1,880 | $0.68 | $1.3K | 110,605 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award deriv | 2020-01-02 | 2020-01-03 | 120,000 | — | $0 | 120,000 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award deriv | 2019-01-02 | 2019-01-04 | 150,000 | — | $0 | 150,000 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award deriv | 2018-02-07 | 2018-02-09 | 70,000 | — | $0 | 70,000 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | M Exercise deriv | 2017-08-11 | 2017-08-15 | 44,313 | — | $0 | 18,247 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | M Exercise deriv | 2017-08-11 | 2017-08-15 | 16,168 | — | $0 | 1,880 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | M Exercise deriv | 2017-08-11 | 2017-08-15 | 36,094 | — | $0 | 0 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | M Exercise deriv | 2017-08-11 | 2017-08-15 | 12,150 | — | $0 | 149,985 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | M Exercise | 2017-08-11 | 2017-08-15 | 44,313 | $2.30 | $101.9K | 96,575 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | M Exercise | 2017-08-11 | 2017-08-15 | 36,094 | $0.68 | $24.5K | 36,094 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | M Exercise | 2017-08-11 | 2017-08-15 | 12,150 | $3.34 | $40.6K | 108,725 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | M Exercise | 2017-08-11 | 2017-08-15 | 16,168 | $0.68 | $11.0K | 52,262 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award deriv | 2017-07-19 | 2017-07-21 | 47,142 | — | $0 | 47,142 | SEC↗ |